Abstract
Biophysical techniques are essential tools in the development and characterization of biotherapeutics. The information gleaned from these techniques about the (higher-order) structure of the molecule provides insight into its behavior as process and formulation conditions are changed, thus helping to identify the optimum conditions for the molecule. Apart from their direct utilization in structural analysis, these techniques are can also be utilized in novel ways to assess comparability and troubleshooting product or process impact (e.g., elucidate aggregation mechanism, or assess aggregation propensity). Combinations of the methods are often required to answer any given question due to the complementary information the methods provide. Case studies involving the use of circular dichroism, differential scanning calorimetry, dynamic light scattering, analytical ultracentrifugation (sedimentation velocity and gravity sweep), isothermal titration calorimetry, intrinsic fluorescence, and extrinsic (steady-state, thermal-scanning, and stopped-flow) fluorescence have been provided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carpenter JF, Randolph TW, Jiskoot W et al (2009) Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. J Pharm Sci 98:1202–1205
Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJA, Middaugh CR, Winter G (2010) Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products. J Pharm Sci 99:2200–2208
Cromwell MEM, Hilario E, Jacobsen F (2006) Protein aggregation and bioprocessing. AAPS J 8:E572–E579
Dam J, Schuck P (2000) Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles. In: Johnson ML, Brand L (eds) Methods in enzymology, vol 384. Part E: numerical computer methods. Elsevier Academic, New York, pp 185–212
Demeule B, Gurny R, Arvinte T (2007) Detection and characterization of protein aggregates by fluorescence microscopy. Int J Pharm 329:37–45
den Engelsman J, Garidel P, Smulders R, Koll H, Smith B, Bassarab S, Seidl A, Hainzl O, Jiskoot W (2011) Strategies for the assessment of protein aggregates in pharmaceutical biotech product development. Pharm Res 28:920–933
Horton N, Lewis M (1992) Calculation of the free energy of association for protein complexes. Protein Sci 1:169–181
ICH Q5E (2005) Comparability of biotechnological/biological products. Available from www.ICH.org
Kelly SM, Price NC (2000) The use of circular dichroism in the investigation of protein structure and function. Curr Protein Pept Sci 1:349–384
Kozlowski S, Swann P (2006) Current and future issues in the manufacturing and development of monoclonal antibodies. Adv Drug Del Rev 58:707–722
Philo JS (2009) A critical review of methods for size characterization of non-particulate protein aggregates. Curr Pharm Biotechnol 10:359–372
Roberts CJ (2006) Non-native protein aggregation: Pathways, kinetics, and shelf-life prediction. In: Murphy RM, Tsai AM (eds) Misbehaving proteins: protein misfolding, aggregation, and stability. Springer, New York, pp 17–46
Sackett DL, Wolff J (1987) Nile red as a polarity-sensitive fluorescent probe for hydrophobic protein surfaces. Anal Biochem 167:228–234
Schuck P (2000) Size distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys J 78:1606–1619
Schuck P (2003) On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Anal Biochem 320:104–124
Singh SK (2011) Impact of product-related factors on immunogenicity of biotherapeutics. J Pharm Sci 100:354–387
Sreerama N, Woody RW (2000) Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal Biochem 287:252–260
Stafford WF, Braswell EH (2004) Sedimentation velocity, multi-speed method for analyzing polydisperse solutions. Biophys Chem 108:273–279
Strickland HE (1974) Aromatic contributions to circular dichroism spectra of proteins. CRC Crit Rev Biochem 2:113–175
Weiss WFI, Young TM, Roberts CJ (2009) Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. J Pharm Sci 98:1246–1277
Zou Q, Luo Y (2010) Biophysical characterization for product comparability. BioPharm Int Suppl 12–17
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Singh, S.K., Zou, Q., Huang, M., Bilikallahalli, M. (2013). Application of Biophysics in Formulation, Process, and Product Characterization: Selected Case Studies. In: Narhi, L. (eds) Biophysics for Therapeutic Protein Development. Biophysics for the Life Sciences, vol 4. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4316-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4316-2_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4315-5
Online ISBN: 978-1-4614-4316-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)